This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (122)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Arrhythmias  • Alert me on articles by topic  Social Bookmarking   What's this?

Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With -Blockers

Silvia G. Priori, MD, PhD; Carlo Napolitano, MD, PhD; Peter J. Schwartz, MD; Massimiliano Grillo, MD; Raffaella Bloise, MD; Elena Ronchetti, PhD; Cinzia Moncalvo, MD; Chiara Tulipani, MD; Alessia Veia, MD; Georgia Bottelli, BS; Janni Nastoli, BS

JAMA. 2004;292:1341-1344.

Context  Data on the efficacy of -blockers in the 3 most common genetic long QT syndrome (LQTS) loci are limited.

Objective  To describe and assess outcome in a large systematically genotyped population of -blocker–treated LQTS patients.

Design, Setting, and Patients  Consecutive LQTS-genotyped patients (n = 335) in Italy treated with -blockers for an average of 5 years.

Main Outcome Measures  Cardiac events (syncope, ventricular tachycardia/torsades de pointes, cardiac arrest, and sudden cardiac death) while patients received -blocker therapy according to genotype.

Results  Cardiac events among patients receiving -blocker therapy occurred in 19 of 187 (10%) LQT1 patients, 27 of 120 (23%) LQT2 patients, and 9 of 28 (32%) LQT3 patients (P<.001). The risk of cardiac events was higher among LQT2 (adjusted relative risk, 2.81; 95% confidence interval [CI], 1.50-5.27; P = .001) and LQT3 (adjusted relative risk, 4.00; 95% CI, 2.45-8.03; P<.001) patients than among LQT1 patients, suggesting inadequate protection from -blocker therapy. Other important predictors of risk were a QT interval corrected for heart rate that was more than 500 ms in patients receiving therapy (adjusted relative risk, 2.01; 95% CI, 1.16-3.51; P = .01) and occurrence of a first cardiac event before the age of 7 years (adjusted RR, 4.34; 95% CI, 2.35-8.03; P<.001).

Conclusion  Among patients with genetic LQTS treated with -blockers, there is a high rate of cardiac events, particularly among patients with LQT2 and LQT3 genotypes.

Author Affiliations: Molecular Cardiology, IRCCS Fondazione Maugeri (Drs Priori, Napolitano, Grillo, Bloise, Ronchetti, Moncalvo, Tulipani, and Veia and Mss Bottelli and Nastoli); Department of Cardiology, IRCCS Policlinico S. Matteo (Dr Schwartz); and University of Pavia (Drs Priori and Schwartz), Pavia, Italy.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genotype-Phenotype Aspects of Type 2 Long QT Syndrome.
Shimizu et al.
J Am Coll Cardiol 2009;54:2052-2062.
ABSTRACT | FULL TEXT  

Routine electrocardiogram and medical history in syncope: a simple approach can identify most high-risk patients
Cerrone and Priori
Europace 2009;11:1411-1412.
FULL TEXT  

Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy.
Spazzolini et al.
J Am Coll Cardiol 2009;54:832-837.
ABSTRACT | FULL TEXT  

Drug-Sensitized Zebrafish Screen Identifies Multiple Genes, Including GINS3, as Regulators of Myocardial Repolarization
Milan et al.
Circulation 2009;120:553-559.
ABSTRACT | FULL TEXT  

Re-evaluating the efficacy of {beta}-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling
Ahrens-Nicklas et al.
Cardiovasc Res 2009;82:439-447.
ABSTRACT | FULL TEXT  

Advances in the prevention of sudden cardiac death in the young
Shephard and Semsarian
Ther Adv Cardiovasc Dis 2009;3:145-155.
ABSTRACT  

Treating the Long-QT Syndrome in the Era of Implantable Defibrillators
Viskin and Halkin
Circulation 2009;119:204-206.
FULL TEXT  

High Efficacy of {beta}-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of {beta}-Blocker Treatment "Failures"
Vincent et al.
Circulation 2009;119:215-221.
ABSTRACT | FULL TEXT  

CHAPTER 9 Genetics of Cardiovascular Diseases
Priori et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Malignant Perinatal Variant of Long-QT Syndrome Caused by a Profoundly Dysfunctional Cardiac Sodium Channel
Wang et al.
Circ Arrhythm Electrophysiol 2008;1:370-378.
ABSTRACT | FULL TEXT  

Therapeutic Strategies for Long-QT Syndrome: Does the Molecular Substrate Matter?
Ruan et al.
Circ Arrhythm Electrophysiol 2008;1:290-297.
FULL TEXT  

Congenital long QT syndrome: Considerations for primary care physicians
LEVINE et al.
Cleveland Clinic Journal of Medicine 2008;75:591-600.
ABSTRACT | FULL TEXT  

Importance of Knowing the Genotype and the Specific Mutation When Managing Patients With Long-QT Syndrome
Moss and Goldenberg
Circ Arrhythm Electrophysiol 2008;1:219-226.
FULL TEXT  

Genotyping Has a Minor Role in Selecting Therapy for Congenital Long-QT Syndromes at Present
Vincent
Circ Arrhythm Electrophysiol 2008;1:227-233.
FULL TEXT  

Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome
Diness et al.
Cardiovasc Res 2008;79:61-69.
ABSTRACT | FULL TEXT  

Long QT syndrome.
Goldenberg and Moss
J Am Coll Cardiol 2008;51:2291-2300.
ABSTRACT | FULL TEXT  

The Year in Review of Clinical Cardiac Electrophysiology
Scheinman and Keung
J Am Coll Cardiol 2008;51:2075-2081.
FULL TEXT  

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
J Am Coll Cardiol 2008;51:e1-e62.
FULL TEXT  

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Writing Committee Members et al.
Circulation 2008;117:e350-e408.
FULL TEXT  

Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome
Goldenberg et al.
Circulation 2008;117:2184-2191.
ABSTRACT | FULL TEXT  

Long-QT Syndrome After Age 40
Goldenberg et al.
Circulation 2008;117:2192-2201.
ABSTRACT | FULL TEXT  

Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement
Heart Rhythm UK Familial Sudden Death Syndromes St
Heart 2008;94:502-507.
ABSTRACT | FULL TEXT  

Antiarrhythmic vs. pro-arrhythmic effects depending on the intensity of adrenergic stimulation in a canine anthopleurin-A model of type-3 long QT syndrome
Chinushi et al.
Europace 2008;10:249-255.
ABSTRACT | FULL TEXT  

Long-QT Syndrome
Roden
NEJM 2008;358:169-176.
FULL TEXT  

The fight against sudden cardiac death: consensus guidelines as a reference
Rossenbacker et al.
Eur Heart J Suppl 2007;9:I50-I58.
ABSTRACT | FULL TEXT  

The Common Long-QT Syndrome Mutation KCNQ1/A341V Causes Unusually Severe Clinical Manifestations in Patients With Different Ethnic Backgrounds: Toward a Mutation-Specific Risk Stratification
Crotti et al.
Circulation 2007;116:2366-2375.
ABSTRACT | FULL TEXT  

Long QT Syndrome in Children: Not One Disease Anymore
Balaji
J Am Coll Cardiol 2007;50:1341-1342.
FULL TEXT  

Long QT Syndrome in Children in the Era of Implantable Defibrillators
Etheridge et al.
J Am Coll Cardiol 2007;50:1335-1340.
ABSTRACT | FULL TEXT  

Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients
Ruan et al.
Circulation 2007;116:1137-1144.
ABSTRACT | FULL TEXT  

Long QT Syndrome in Adults
Sauer et al.
J Am Coll Cardiol 2007;49:329-337.
ABSTRACT | FULL TEXT  

Prevalence of Long-QT Syndrome Gene Variants in Sudden Infant Death Syndrome
Arnestad et al.
Circulation 2007;115:361-367.
ABSTRACT | FULL TEXT  

Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3
Thomas et al.
J. Physiol. 2007;578:85-97.
ABSTRACT | FULL TEXT  

Sudden Death and Long-QT Syndrome
Saarel
AAP Grand Rounds 2006;16:62-63.
FULL TEXT  

Altered Na+ Channels Promote Pause-Induced Spontaneous Diastolic Activity in Long QT Syndrome Type 3 Myocytes
Fredj et al.
Circ. Res. 2006;99:1225-1232.
ABSTRACT | FULL TEXT  

Genotype-Specific Onset of Arrhythmias in Congenital Long-QT Syndrome: Possible Therapy Implications
Tan et al.
Circulation 2006;114:2096-2103.
ABSTRACT | FULL TEXT  

Does Pregnancy Increase Cardiac Risk for LQT1 Patients With the KCNQ1-A341V Mutation?
Heradien et al.
J Am Coll Cardiol 2006;48:1410-1415.
ABSTRACT | FULL TEXT  

Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome.
Hobbs et al.
JAMA 2006;296:1249-1254.
ABSTRACT | FULL TEXT  

Corrected QT Variability in Serial Electrocardiograms in Long QT Syndrome: The Importance of the Maximum Corrected QT for Risk Stratification
Goldenberg et al.
J Am Coll Cardiol 2006;48:1047-1052.
ABSTRACT | FULL TEXT  

QT Interval Duration Remains a Major Risk Factor in Long QT Syndrome Patients
Locati
J Am Coll Cardiol 2006;48:1053-1055.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
Developed in Collaboration With the European Heart et al.
J Am Coll Cardiol 2006;48:e247-e346.
FULL TEXT  

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:746-837.
FULL TEXT  

Effects of Beta-Blocker Therapy on Ventricular Repolarization Documented by 24-h Electrocardiography in Patients With Type 1 Long-QT Syndrome
Viitasalo et al.
J Am Coll Cardiol 2006;48:747-753.
ABSTRACT | FULL TEXT  

Cost-effectiveness of neonatal ECG screening for the long QT syndrome
Quaglini et al.
Eur Heart J 2006;27:1824-1832.
ABSTRACT | FULL TEXT  

Molecular Underpinning of "Good Luck"
Priori and Napolitano
Circulation 2006;114:360-362.
FULL TEXT  

Dental treatment of patients with long QT syndrome
Karp and Moss
Journal of the American Dental Association 2006;137:630-637.
ABSTRACT | FULL TEXT  

Epinephrine QT Stress Testing in the Evaluation of Congenital Long-QT Syndrome: Diagnostic Accuracy of the Paradoxical QT Response
Vyas et al.
Circulation 2006;113:1385-1392.
ABSTRACT | FULL TEXT  

Role of Genetic Analyses in Cardiology: Part I: Mendelian Diseases: Cardiac Channelopathies
Priori and Napolitano
Circulation 2006;113:1130-1135.
ABSTRACT | FULL TEXT  

The Jervell and Lange-Nielsen Syndrome: Natural History, Molecular Basis, and Clinical Outcome
Schwartz et al.
Circulation 2006;113:783-790.
ABSTRACT | FULL TEXT  

Genetic Testing in the Long QT Syndrome: Development and Validation of an Efficient Approach to Genotyping in Clinical Practice
Napolitano et al.
JAMA 2005;294:2975-2980.
ABSTRACT | FULL TEXT  

Efficient Genotyping for Congenital Long QT Syndrome
Kaufman
JAMA 2005;294:3027-3028.
FULL TEXT  

Phenotypic Variability and Unusual Clinical Severity of Congenital Long-QT Syndrome in a Founder Population
Brink et al.
Circulation 2005;112:2602-2610.
ABSTRACT | FULL TEXT  

Genetics of cardiac arrhythmias
Wilde and Bezzina
Heart 2005;91:1352-1358.
FULL TEXT  

The long QT syndrome: Therapeutic implications of a genetic diagnosis
Shimizu
Cardiovasc Res 2005;67:347-356.
ABSTRACT | FULL TEXT  

The year in clinical electrophysiology
Scheinman and Keung
J Am Coll Cardiol 2005;45:790-795.
FULL TEXT  

Cardiac repolarization. The long and short of it
Antzelevitch
Europace 2005;7:S3-S9.
ABSTRACT | FULL TEXT  

How Effective Are Beta-Blockers for Long-QT Syndrome?
Journal Watch Cardiology 2004;2004:3-3.
FULL TEXT